{"id":52100,"date":"2022-12-16T20:02:17","date_gmt":"2022-12-16T19:02:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/worldwide-ngs-market-forecasted-to-grow-at-15-p-a-to-reach-9-3b-in-2025-market-report-by-decibio-consulting\/"},"modified":"2022-12-16T20:02:17","modified_gmt":"2022-12-16T19:02:17","slug":"worldwide-ngs-market-forecasted-to-grow-at-15-p-a-to-reach-9-3b-in-2025-market-report-by-decibio-consulting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/worldwide-ngs-market-forecasted-to-grow-at-15-p-a-to-reach-9-3b-in-2025-market-report-by-decibio-consulting\/","title":{"rendered":"Worldwide NGS Market Forecasted to Grow at 15% p.a., to Reach ~$9.3B in 2025 \u2013 Market Report by DeciBio Consulting"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–#marketreport<\/a>–DeciBio Consulting LLC\u2019s latest market report, \u201cNext Generation Sequencing (NGS) Market Size, Growth and Trends (2019-2025),\u201d predicts that the Next generation Sequencing market will grow to ~$9.3 billion (USD) in 2025 driven primarily by clinical adoption in oncology settings across the patient journey, including early detection and monitoring.\n<\/p>\n

<\/a><\/p>\n

\nThis 8th<\/sup> edition report, published to provide granularity on the \u201cpost-pandemic\u201d market landscape, incorporates latest NGS trends and updates old market trends for each market segment while reevaluating the potential of high-growth applications. The market numbers provided are updated using secondary research and latest trends up to Q3 2022 in light of several factors.\n<\/p>\n

\nDeciBio\u2019s co-founder and report\u2019s primary author Stephane Budel said: \u201cWe\u2019ve been monitoring the NGS manufacturer market for more than a decade, and I\u2019m particularly excited about 2023! Many applications such as MRD and early cancer detection are gaining traction, and the competitive landscape is more dynamic than ever. NGS is unstoppable. This technology will continue to transform the tools and diagnostic space and drive disruption in precision medicine, and shape the future of healthcare.\u201d\n<\/p>\n

\nNext Generation Sequencing (NGS) has transformed the life sciences and diagnostics landscapes. This technology is used for applications including human whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing using panels of a few-to-thousands of genes, and expression profiling (e.g., RNA-Seq). 2022 proved to be another anomaly, with many factors contributing to a relatively weak year for a market with a long runway and strong growth prospects across multiple applications. Looking at the next 3 years, despite a challenging macroeconomic environment and dropping cost per gigabyte, we forecast a growth of ~15% p.a. (vs. 13% in the last 3 years).\n<\/p>\n

\nReport Methodology \/ Scope:<\/b>\n<\/p>\n\n\n\n\n\n\n\n\n\n\n
\n

\nReport Details\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nResearch Methods\n<\/p>\n<\/td>\n

\n
    \n
  • \nPrimary Research\n<\/li>\n
  • \nSecondary Research\n<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
\n

\n2025 Market size\n<\/p>\n<\/td>\n

\n

\n$9.3 billion\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nCAGR (2022 \u2013 2025)\n<\/p>\n<\/td>\n

\n

\n15%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nBase Year\n<\/p>\n<\/td>\n

\n

\n2022 (current)\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nForecast Period\n<\/p>\n<\/td>\n

\n

\n2022-2025\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nMarket \/ Forecast Currency\n<\/p>\n<\/td>\n

\n

\nUSD\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nReport Coverage\n<\/p>\n<\/td>\n

\n

\nMarket size, segmentation, and forecast; key market players and trends; assays and technologies; market drivers and moderators; competitive analysis; quotes from clinical and research stakeholders\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nSegments Covered\n<\/p>\n<\/td>\n

\n